










































The mother or the fetus? 11 beta-hydroxysteroid dehydrogenase
type 2 null mice provide evidence for direct fetal programming of
behavior by endogenous glucocorticoids
Citation for published version:
Holmes, MC, Abrahamsen, CT, French, KL, Paterson, JM, Mullins, JJ & Seckl, JR 2006, 'The mother or the
fetus? 11 beta-hydroxysteroid dehydrogenase type 2 null mice provide evidence for direct fetal
programming of behavior by endogenous glucocorticoids' Journal of Neuroscience, vol. 26, no. 14, pp.
3840-3844. DOI: 10.1523/JNEUROSCI.4464-05.2006
Digital Object Identifier (DOI):
10.1523/JNEUROSCI.4464-05.2006
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




Copyright © 2013 by the Society for Neuroscience
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Development/Plasticity/Repair
TheMother or the Fetus? 11-HydroxysteroidDehydrogenase
Type 2 Null Mice Provide Evidence for Direct Fetal
Programming of Behavior by Endogenous Glucocorticoids
Megan C. Holmes,1 Christian T. Abrahamsen,1 Karen L. French,1 Janice M. Paterson,2 John J. Mullins,2 and
Jonathan R. Seckl1
1Endocrinology Unit and 2Molecular Physiology Laboratory, Centre for Cardiovascular Disease, Queen’s Medical Research Institute, University of
Edinburgh, Edinburgh EH16 4TJ, United Kingdom
Low birth weight associates with increased susceptibility to adult cardiometabolic and affective disorders spawning the notion of fetal
“programming.” Prenatal exposure to excess glucocorticoids may be causal. In support, maternal stress or treatment during pregnancy
with dexamethasone (which crosses the placenta) or inhibitors of fetoplacental 11-hydroxysteroid dehydrogenase type 2 (11-HSD2),
the physiological “barrier” to maternal glucocorticoids, reduces birth weight and programs permanent offspring hypertension, hyper-
glycemia, and anxiety behaviors. It remains uncertain whether such effects are mediated indirectly via altered maternal function or
directly on the fetus and its placenta. Todissect this critical issue,wemated 11-HSD2/mice such that eachpregnant female produces
/,/, and/ offspring and compared them with offspring of homozygous wild-type and/ matings. We show that 11-
HSD2/ offspring of either/ or/mothers have lower birth weight and exhibit greater anxiety than 11-HSD2/ littermates.
This provides clear evidence for the key role of fetoplacental 11-HSD2 in prenatal glucocorticoid programming.
Keywords: anxiety; hypothalamic–pituitary–adrenal axis; glucocorticoids; programming; behavior; 11-hydroxysteroid dehydrogenase
Introduction
An adverse prenatal environment “programs” lifelong suscepti-
bility to adult disorders such as hypertension, diabetes/insulin
resistance, heart disease, as well as depression and schizophrenia
(Barker, 2004; Eriksson et al., 2004; Huizink et al., 2004). Studies
in several model species have shown that exposure of a pregnant
female to repeated stress or to the synthetic glucocorticoid dexa-
methasone, which crosses the placenta, reduces offspring birth
weight and causes lifelong hypertension, hyperglycemia, hypo-
thalamic–pituitary–adrenal (HPA) axis hyperactivity, and
anxiety-related behaviors in adult life (Seckl, 2004). Intriguingly,
prenatal exposure of humans to dexamethasone is subsequently
associated with elevated blood pressure (Doyle et al., 2003), hy-
perinsulinemia (Dalziel et al., 2005), and altered emotionality in
later life (Trautman et al., 1995).
Normally, the fetus is protected, at least in large part, from the
much higher levels of glucocorticoids (corticosterone in rats and
mice, cortisol in other mammals) in the maternal blood by pla-
cental 11-hydroxysteroid dehydrogenase type 2 (11-HSD2). This
catalyzes the rapid inactivationof cortisol andcorticosterone to their
inert 11-keto forms (cortisone, 11-dehydrocorticosterone). In adult
life, 11-HSD2 is highly expressed in the kidney, where it ex-
cludes active glucocorticoids from mineralocorticoid receptors
(MRs) in vivo, thus allowing aldosterone selective access. Con-
genital deficiency of 11-HSD2 or its inhibition by liquorice de-
rivatives allows activation of MRs by glucocorticoids causing hy-
pernatremia, hypertension, and hypokalemia; the syndrome of
apparent mineralocorticoid excess (AME) (Stewart et al., 1988;
White et al., 1997).
The placenta and the fetal brain highly express 11-HSD2
until the end of midgestation (Brown et al., 1996; Waddell et al.,
1996). It has been proposed that relative deficiency of placental
and/or fetal 11-HSD2, by allowing greater passage of maternal
glucocorticoids to fetal tissues,might be the physiological parallel
to the effects of dexamethasone, a poor substrate for 11-HSD2,
which crosses the placenta. In support of this notion, activity of
placental 11-HSD2 correlates with birth weight (Lindsay et al.,
1996; Welberg et al., 2000; Murphy et al., 2002). Moreover, in
rats, maternal treatment during pregnancy with dexamethasone
or the nonselective 11-HSD inhibitor carbenoxolone reduces
birth weight and produces permanent hypertension, hyperglyce-
mia, and behavior reminiscent of anxiety (Lindsay et al., 1996;
Welberg et al., 2000, 2001). However, because all prenatalmodels
used to date involvematernalmanipulations, the locus of effect is
unknown. This is crucial because postnatallymaternal behavioral
factors are major critical influences determining offspring brain
programming (Liu et al., 2000; Weaver et al., 2004).
In this paper, we test the hypothesis that 11-HSD2 expres-
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sion in the placenta and fetus protects the fetus from overexpo-
sure to maternal glucocorticoids in the mouse, resulting in pro-
gramming of the offspring. The phenotype of 11-HSD2/
mice has been reported (Kotelevtsev et al., 1999); however, the
targeted 11-HSD2 allele has now been backcrossed onto the
C57BL/6J strain, which exhibits a much milder phenotype of
systolic hypertension (8mmHg) in young adult offspring (J.M.
Paterson, M. A. Bailey, P. W. F. Hadoke, D. G. Brownstein, C.
Bellamy, S. Fleming, J. R. Seckl, and J. J. Mullins, unpublished
observations). We have now examined the effects of 11-HSD2
nullizygosity on offspring’s behavior and HPA activity.
Materials andMethods
Animals
For homozygous matings of C57BL/6J or 11-HSD2/ congenic on
C57BL/6J background, amale and female of the respective genotypewere
housed together in a breeding cage with bedding for nest building.
In other experiments, male and female 11-HSD2/mice congenic
on the C57BL/6J background were housed in pairs in a breeding cage as
above. Offspring consisting of 11-HSD2 /, /, and / were
compared within the same litter. Genotyping was performed by PCR
using these primers: B2Forw, AACGGGCTCCAAGTTGAGTC; B2Rev,
GCTTCAGGCGAGGAGAACAGAGGTCACG; NEORev, CGCTTCC-
TCGTGCTTTACGGTATCGCCGCTCC.
Animalswere given standard chowandwater ad libitum, lightswere on
from 7 A.M. to 7 P.M., and all studies were performed to the highest
standards of humane animal care under the aegis of the United Kingdom
Animals (Scientific Procedures) Act, 1986. All pups were weighed on the
day of birth and/or at the time of killing.
Behavioral testing
Adult male mice were tested in two types of behavioral tasks in a random
order. Immediately before the testing, mice were brought into the testing
room in their home cage, and testing started immediately with no accli-
matization period.Mice were group housed, and nomore than twomice
from each cage were tested. No differences were seen betweenmouse 1 or
2 from a cage or whethermice were tested in an apparatus first or second.
Three days were allowed between tests on each apparatus. Tests were
videotaped or captured by a computer tracking program (Limelight;
Actimetrics, Wilmette, IL) to allow full analysis.
Open field test. Mice were placed in an open field (OF) box (60  60
cm) marked off into 25 equal squares. The outer row of squares adjacent
to the walls of the field are considered less anxiogenic than the inner
squares. For a 5 min period, the number of crossings, time, and distance
(movement of all four legs into a new square) into each squarewas noted.
Total movement in the maze reflects general activity and the relative
movement in the inner zone is correlated to the anxiety state of the
mouse.
Elevated plus maze. Mice were placed on the central region of the
elevated plus maze (EPM) (two intercrossing arms of white plastic,90
cm long and 5 cmwide; twoopposite arms are enclosed and two are open,
and the maze is elevated 1 m from the floor), and movement around
the maze for 5 min was assessed. The open arms are considered a more
anxiogenic environment, and so crossing, movement, and time spent on
these arms compared with total movement is a reflection of anxiety state.
HPA axis activity
Male mice as adults (2 months of age) were tested for HPA axis func-
tion. Basal blood samples were taken from a tail nick at 8 A.M., the nadir
of the corticosterone diurnal rhythm, and peak stress samples were taken
from trunk blood after 10 min in a Perspex restraint tube. At time of
killing, brains were collected and rapidly frozen on dry ice and stored at
–80°C until processed further for gene expression. Adrenals were also
collected in some animals, which were cleaned of fat and weighed.
In situ hybridization for glucocorticoid receptor and MR steady-
state mRNA expression
Coronal cryostat sections (10 m) at the level of the hippocampus were
mounted onto gelatin- and poly-L-lysine-coated slides and stored at
80°C. In situ hybridization studies were performed according toHarris
et al. (2001). Plasmids containing fragments of cDNA for rat glucocorti-
coid receptor (GR) (1691–2364 bp) and MR (2769–3282 bp) were used
as templates to transcribe radiolabeled sense and antisense riboprobes
using 35S-UTP (Amersham Biosciences, Little Chalfont, UK). Following
the hybridization protocol, the slides were exposed to autoradiographic
film for 1 week at room temperature. Five to 10 readings were taken from
each region of each tissue section (three sections per mouse). Sections
were dipped in photographic emulsion (NTB2; Kodak, Rochester, NY)
and stored at 4°C before development and counterstaining with pyronin
(1%, w/v). Grain counting was performed using an MCID system (Im-
aging Research, St. Catharines, Ontario, Canada).
Analysis of plasma corticosterone
Trunkbloodwas collected into EDTA-coatedMicrovette tubes (Sarstedt,
Numbrecht, Germany) and centrifuged, and then plasma was stored at
–20°C until corticosterone determination by radioimmunoassay as de-
scribed previously (Holmes et al., 1997).
Statistical analysis
All data are expressed as group means  SEM. Statistical significance
between groups was determined by one- or two-way ANOVA followed
by Dunnett’s post hoc test, or Student’s t test, as appropriate.
Results
Birth weight and growth are altered in 11-HSD2/mice
There was no difference in the size of the litters produced by
C57BL/6J matings or 11-HSD2/ matings (C57BL/6J, 7.2 
0.4, n  21; 11-HSD/, 6.4  0.6, n  28). However, the
weight of pups born from 11-HSD2/male and female pairs
was significantly less than C57BL/6J controls (C57BL/6J, 1.33
0.019 g, n 32; 11-HSD2/, 1.21 0.023 g, n 34; p 0.01).
11-HSD2/ mice remained smaller throughout life (e.g., 9
months of age, C57BL/6J, 38.83  1.52 g, and 11-HSD2/,
30.08  0.78 g; n  10); this might be attributable to either
altered programmed growth trajectories and/or their AME
phenotype.
To determine whether the differences between the birth
weights and subsequent growth trajectories of 11-HSD2/
and 11-HSD2/ mice were attributable to loss of 11-HSD2
in the mother (i.e., AME-induced alterations in maternal physi-
ology, health, and/or behavior including the “AME” uterine en-
vironment) or attributable to lack of 11-HSD2 in fetoplacental
tissues, heterozygous (11-HSD2/) male and female pairs of
mice were mated, and the various genotypes of offspring within
the same heterozygous mother compared. Strikingly, birth
weight followed offspring genotype, with wild-type the heaviest
offspring, heterozygotes intermediate, and 11-HSD2/ off-
spring the lightest at birth (Fig. 1). Thus, birth weight reduction
with deficiency of 11-HSD2 reflects loss of the enzyme in the
fetoplacental compartment and does not require maternal AME.
Postnatal catch-up growth, well recognized in human low birth
weight cohorts, and several animal models, was observed in the
11-HSD2/ and 11-HSD2/ offspring such that, at post-
natal day 7 (P7) and P15, there were no significant differences in
body weights between the genotypes (supplemental Table 1,
available at www.jneurosci.org as supplemental material), which
continued into adulthood. Thus, persisting weight deficits in the
offspring of 11-HSD2/ matings reflect aspects of maternal
biology rather than lack of the enzyme in the fetoplacental com-
partment or offspring AME per se.
Anxiety behavior is observed in 11-HSD2/mice
Administration of 11-HSD inhibitors or nonsubstrate glu-
cocorticoids such as dexamethasone in pregnant rats programs
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anxiety behavior in the offspring. In the EPM anxiety test, 11-
HSD2/ mice made significantly fewer entries into the more
anxiogenic open arms and spent less time there, indicating ele-
vated anxiety (Fig. 2). However, total activity on the maze was
similar between genotypes (total entries: C57BL/6J, 15.5  1.3,
n  26; 11-HSD2/, 15.7  1.15, n  26). To confirm this
finding, 11-HSD2/ and wild-type C57BL/6J mice were fur-
ther examined for anxiety-like behavior in the OF test. 11-
HSD2/ mice exhibited significantly fewer crossings into the
anxiogenic inner area (expressed as a percentage of total crossings
throughout the maze to control for locomotion) compared with
wild-type (C57BL/6J: 31.1  1.6%, n  26; 11-HSD2/:
23.7 2.3%, n 34; p 0.05), implying greater anxiety-related
behavior. There was no significant difference in total crossings
between the 2 genotypes (C57BL/6J: 188.7 12.8, n 26; 11-
HSD2/: 212  10.5, n  26). Maternal care is important in
determining offspring behavior. Therefore we tested anxiety be-
havior in 11-HSD2/,/, and/ littermates from het-
erogygous matings. 11-HSD2/ offspring showed decreased
open arm entries and decreased distance traveled in the open
arms compared with their wild-type littermates from the same
mother (Fig. 3a,b), paralleling the anxiety phenotype of 11-
HSD2/ mice from 11-HSD2/ mothers. However, per-
formance in the open field was similar between genotypes (per-
centage of inner crossings: C57BL/6J, 17  2.3%, n  9;
11-HSD2/, 20.2  1.8%, n  15; 11-HSD2/, 16.4 
3.2%, n  7; total activity/crossings: C57BL/6J, 156.6  17.9;
11-HSD2/, 199.1 11.8; 11-HSD2/, 218.4 21.1), sug-
gesting a maternal component may also be contributing to a
more robust anxiogenic phenotype in 11-HSD2/mice from
a 11-HSD2/mother.
HPA axis activity is unchanged in 11-HSD2/mice
As offspring from rats and other species prenatally exposed to
dexamethasone, carbenoxolone, or stress have permanently al-
tered HPA axis activity, we investigated the HPA function in
adult male 11-HSD2/ mice. Adrenal weights from 11-
HSD2/mice were significantly smaller than controls (ratio of
adrenal weight/body weight (105): wild type, 5.2 0.5; 11-
HSD2/, 4.1 0.3; n 10; p 0.05), suggesting a compensa-
tory downward resetting of HPA function in the absence of ca-
tabolism of active corticosterone by 11-HSD2. Adrenal
hypotrophy was also observed in 11-HSD2/ mice derived
fromheterozygousmatings (11-HSD2/, 1.87 0.09mg, n
18; 11-HSD2/, 1.9 0.05mg,n 32; 11-HSD2/, 1.59
0.07 mg, n 16), confirming the phenotype is dependent on the
11-HSD2 genotype of the fetus, rather than themother. Despite
this, in adult offspring from 11-HSD2/ matings, both basal
and peak stress (10 min restraint) plasma corticosterone levels
weremaintained at control C57BL/6J levels (supplemental Fig. 1,
available at www.jneurosci.org as supplemental material). Fur-
thermore, MR and GR mRNA levels within the hippocampus as
well as GRmRNA in the paraventricular nucleus of the hypothal-
amus, targets altered with prenatal glucocorticoid programming
and sensitive to tissue corticosterone levels (Holmes et al., 1995;
Levitt et al., 1996; Welberg et al., 2001), were not significantly
different between control and 11-HSD2/mice (supplemen-
tal Table 2, available at www.jneurosci.org as supplemental ma-
terial). Hence, regulation of the HPA axis appears to be un-
changed/reset by the absence of 11-HSD2. Moreover, basal and
Figure 1. Birth weights of 11-HSD2/ (filled columns), 11-HSD2/ (striped col-
umns), and 11-HSD2/ (open columns) offspring from 11-HSD2/matings. The col-
umns represent means SEM. *p 0.05 compared with 11-HSD2/ controls.
Figure 2. 11-HSD2/mice from homozygous matings show increased anxiety in ele-
vated plus maze test. 11-HSD2/mice (open columns) show decreased number of entries
and time spent in open arms of EPM comparedwith 11-HSD2/mice (filled columns). The
columns representmeans SEM. n 26. *p 0.05 comparedwith 11-HSD2/ control.
Figure 3. 11-HSD2/mice from heterozygous matings show increased anxiety in the
elevated plus maze test. Open arm entries (a) and distance traveled in open arms (b) in 11-
HSD2/ (filled columns), 11-HSD2/ (striped columns), and HSD/ (open columns)
littermates are shown. The columns representmeans SEM. *p 0.05 comparedwith 11-
HSD2/ control.
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poststress plasma corticosterone levels in all genotypes from het-
erozygous matings were similar (supplemental Fig. 1, available at
www.jneurosci.org as supplemental material).
Discussion
The key issue addressed in this research is to define the target for
prenatal programming by glucocorticoids: the mother or the fe-
toplacental unit? The results suggest that 11-HSD2 deficiency,
and hence exposure to excess glucocorticoids, reduces birth
weight and programs the fetal brain. Furthermore, loss of feto-
placental enzyme is sufficient to cause much of this without in-
direct maternal effects; however, a component of maternal com-
ponent exaggerates the effects.
Lack of 11-HSD2 activity results in low birth weight and
altered growth
11-HSD2/matings produced lighter offspring than congenic
C57BL/6J controls, implicating the enzyme in the control of fetal
growth and birth weight. This finding recapitulates results with
11-HSD inhibitors in the pregnant rat (Lindsay et al., 1996;
Welberg et al., 2000). However, 11-HSD2 is expressed in the
maternal kidney and plays a key role in maternal fluid and elec-
trolyte balance and hence blood pressure control (Kotelevtsev et
al., 1999). Moreover, carbenoxolone also inhibits 11-HSD1, an
oxidoreductase that locally regenerates glucocorticoids and is ex-
pressed in liver and adipose tissue and plays a key role in meta-
bolic control (Morton et al., 2004). 11-HSD1 is also expressed
in the uterus and decidua, so dissecting the locus of effect of
carbenoxolone is complex. However, because birth weight also
followed fetal 11-HSD2 genotype within the same (heterozy-
gous) mother, the results here demonstrate that reduced birth
weight is an effect of allowing excessive glucocorticoid action on
the fetus and/or placental trophoblast rather than any effects me-
diated via changes inmaternal blood pressure ormetabolism. It is
intriguing that there was a significant gene dosage effect with
heterozygous offspring intermediate in birth weight. This sup-
ports the hypothesis that variation in placental 11-HSD2 activ-
ity, by allowing excessive fetal exposure to maternal glucocorti-
coids, links the maternal environment with fetal growth and
development. Until this work, this notion has been dependent on
correlational analyses only. Whether exogenous agents such as
dexamethasone, stress, and carbenoxolone only act on birth
weight via fetoplacental actions alone or also have maternal ef-
fects remains uncertain, but the data here show that fetoplacental
effects are sufficient.
In contrast, postnatal growth trajectories differed between the
offspring of 11-HSD2/ matings and 11-HSD2/ off-
spring of heterozygousmatings. 11-HSD2/ offspring of 11-
HSD2/ mothers did not exhibit catch-up growth postnatally
and remained 20–25% lighter than congenic C57BL/6J controls
into midlife, whereas genetically identical 11-HSD2/ off-
spring of 11-HSD2/mothers showed full catch-up growth by
weaning and had the same adult weight as wild-type littermates.
This cannot easily be ascribed to the postnatal AME syndrome,
which is mild on this genetic background and is anticipated to be
similar in the two situations. It is conceivable that the growth
retardationwasmoremarked in 11-HSD2/ offspring of 11-
HSD2/ than 11-HSD2/ mothers because of a greater
growth retardation signal in offspring of the more biologically
abnormal mothers, although this was not marked by a greater
reduction in birth weight. More plausibly, the discordance may
reflect differences in maternal care and/or nutrient provision
postnatally. In support of this contention, lactating female 11-
HSD2/mice alone have appreciable mortality (Paterson et al.,
2005), presumed to reflect exacerbation of already abnormalma-
ternal fluid and electrolyte handling at a time of challenge.What-
ever thematernal mechanism involved, the lack of early catch-up
growth in 11-HSD2/ offspring of 11-HSD2/ mothers,
but not of 11-HSD2/mothers, persists after weaning, imply-
ing that the combination of prenatal and postnatal growth retar-
dation cannot be readily reversed. This is reminiscent of studies
with nutritional restriction prenatally and/or postnatally in
which catch-up growth after prenatal restriction is attenuated
after additional postnatal constraint, perhaps because of perma-
nent changes in hypothalamic appetitive circuitry (Desai et al.,
2005).
11-HSD2-null mice show programming of anxiety behavior
11-HSD2 is highly expressed in the adult kidney, where it po-
tently influences blood pressure, making assessment of any fetal
programming of cardiovascular characteristics unfeasible in 11-
HSD2/models. In contrast, the adult mouse forebrain has no
11-HSD2 (limited expression in rat forebrain is not observed in
the mouse). Conversely, plentiful 11-HSD2 is present in the
fetal CNS until the end of midgestation with the subsequent pat-
terns of loss of 11-HSD2 paralleling terminal differentiation of
particular regions (Brown et al., 1996; Diaz et al., 1998). Thus,
any CNS programming likely reflects developmental effects.
Anxiety behavior is found in rodentmodels of prenatal program-
ming by dexamethasone administration (Welberg et al., 2001),
prenatal stress (Welberg et al., 2001; Maccari et al., 2003), or
inhibition of 11-HSD by carbenoxolone (Welberg et al., 2000);
but all involve manipulation of the mother, and therefore mater-
nal physiology and behavior may contribute to fetal abnormali-
ties. Here, we show increased anxiety-related behaviors seen in
11-HSD2/ offspring of 11-HSD2/ and 11-HSD2/
mothers, suggesting it is predominantly attributable to fetal ef-
fects rather than alterations of maternal physiology or behavior.
Interestingly, anxiety phenotypes were not observed in 11-
HSD2/ heterozygote littermates, although these have an inter-
mediate birthweight phenotype. It is unclearwhether this reflects
the insensitivity of the CNS to glucocorticoid programming of
behavior or insensitivity of methods of assessment of affective
function in mice.
However, whereas anxiety-related behavior in the EPM was
similar in 11-HSD2/ offspring of either 11-HSD2/ or
11-HSD2/mothers, open field behavior was abnormal only
in 11-HSD2/ offspring of 11-HSD2/mothers. This im-
plies that, as with postnatal growth, aspects of adult behavior are
also influenced by maternal factors, perhaps an unsurprising
finding but nonetheless important in the strictly genetically and
endocrinologically confined contexts of the models used here. In
this perspective, prenatal stress programs altered adult behavior,
but effects are powerfully influenced by early postnatal environ-
mental manipulations.
Loss of 11-HSD2 activity has no effect on HPA axis activity
In most model species, prenatal programming, including by glu-
cocorticoids, carbenoxolone, or stress, induces lifelong alter-
ations (typically increases) in HPA axis activity (Maccari et al.,
1995; Weinstock, 1997; Welberg et al., 2000). Low birth weight
human cohorts have increased HPA activity. However, 11-
HSD2/ mice, whether from 11-HSD2/ mothers with
AME or apparently healthy heterozygous 11-HSD2/ moth-
ers, had no alterations of HPA parameters. This seemingly sur-
prising finding has several possible explanations. First, themouse
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(as a species) may not be susceptible to programming of the HPA
axis in general (unlikely) or theC57BL/6J strainmay be unusually
resistant to HPA axis hyperactivity (R. Carter, Paterson, and M.
C. Holmes, unpublished observation). Second, the mild hyper-
tension and electrolyte imbalance in adult C57BL/6J–11-
HSD2/ mice throughout life may serve to “reset” HPA axis
activity, although how this might occur is moot. Third, the “nor-
mal” HPA function in 11-HSD2/mice might be considered
surprising because the reduced clearance of corticosterone in
11-HSD2/ mice and thus the lower activity of the HPA axis
needed to maintain circulating corticosterone levels (as evi-
denced by adrenal hypoplasia) is anticipated to attenuate HPA
responses to stress. Perhaps fetal HPA axis programming is in-
deed seen in bothmodels and is reflected by paradoxically normal
HPA responses to stress when hypoactivity is expected. However,
an important feature of the 11-HSD2/ mouse is that the
behavioral effects of early life glucocorticoid overexposure are
clearly independent of HPA axis hyperactivity, removing adult
elevated glucocorticoids as being the primary cause of the anxiety
phenotype.
Summary
In conclusion, we have shown that loss of 11-HSD2 activity
results in an early life exposure to high maternal glucocorticoids,
resulting in low birth weight and a programmed behavioral phe-
notype of increased anxiety. At present, we cannot exclude the
lifelongmild hypertension and electrolyte imbalance attributable
to loss of kidney 11-HSD2 activity having a role in altering
behavior, nor can we determine for sure the relative importance
of placental versus fetal brain 11-HSD2 protection. These
points will be addressed in future studies involving conditional
knock-out of 11-HSD2. This is the first model of programming
that unequivocally demonstrates the importance of 11-HSD2 in
the fetus and placenta in a situation that rules out maternal
pathophysiology and behavior as contributing factors.
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